首页> 美国卫生研究院文献>other >N-Picolyl Derivatives of Kemp’s Triamine as Potential Antitumor Agents: A Preliminary Investigation
【2h】

N-Picolyl Derivatives of Kemp’s Triamine as Potential Antitumor Agents: A Preliminary Investigation

机译:肯普三胺的N-Picolyl衍生物作为潜在的抗肿瘤药物:初步调查

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Pre-organized tripodal ligands such as the N-picolyl derivatives of cis,cis-1,3,5-triamino-cis,cis-1,3,5-trimethylcyclohexane (>Kemp’s triamine) were prepared as analogs to N,N’,N”- tris(2-pyridylmethyl)-cis,cis-1,3,5-triaminocyclohexane (>tachpyr) in hopes of enhancing the rate of formation and stability of the metal complexes. A tricyclic bisaminal was formed via the reduction of the Schiff base while the tri(picolyl) derivative was synthesized via reductive amination of pyridine carboxaldehyde. Their cytotoxicities to the HeLa cell line were evaluated and directly compared to tachpyr and N,N’,N”- tris(2-pyridylmethyl)-tris(2-aminoethyl)amine (>trenpyr). Results indicate that N,N’,N”-tris(2-pyridylmethyl)-cis,cis-1,3,5-triamino-cis,cis-1,3,5-trimethylcyclohexane (>Kemp’s pyr) exhibits cytotoxic activity against the HeLa cancer cell line comparable to tachpyr (IC50 ~ 8.0 µM). Both Kemp’s pyr and tachpyr show higher cytotoxic activity over the aliphatic analogue of trenpyr (IC50 ~ 14 µM) suggesting that the major contributor to the activity is the ligand’s ability to form a stable and tight complex and that the equatorial/axial equilibrium impacting the complex formation for the cyclohexane-based ligands is not significant.
机译:制备了预组织的三脚架配体,例如顺式,顺式-1,3,5-三氨基-顺式,顺式1,3,5-三甲基环己烷()的N-吡啶甲基衍生物N,N',N”-三(2-吡啶基甲基)-顺,cis-1,3,5-三氨基环己烷(> tachpyr )的类似物,希望提高其形成速率和稳定性金属配合物。通过还原席夫碱形成三环双缩醛,而通过吡啶甲醛的还原胺化合成三(吡啶甲基)衍生物。评估了它们对HeLa细胞系的细胞毒性,并将其与tachpyr和N,N’,N”-三(2-吡啶基甲基)-三(2-氨基乙基)胺(> trenpyr )进行了直接比较。结果表明,N,N',N”-三(2-吡啶基甲基)-顺,顺-1,3,5-三氨基-顺,顺-1,3,5-三甲基环己烷(> Kemp's pyr )对HeLa癌细胞系表现出与tachpyr(IC50〜8.0 µM)相当的细胞毒性活性。 Kemp的pyr和tachpyr均显示出比trenpyr的脂肪族类似物更高的细胞毒活性(IC50〜14 µM),表明该活性的主要贡献是配体形成稳定且紧密的复合物的能力以及赤道/轴向平衡影响该复合物基于环己烷的配体的形成并不重要。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号